William Tabayoyong

747 total citations
27 papers, 526 citations indexed

About

William Tabayoyong is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, William Tabayoyong has authored 27 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in William Tabayoyong's work include Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (6 papers) and Prostate Cancer Treatment and Research (6 papers). William Tabayoyong is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (6 papers) and Prostate Cancer Treatment and Research (6 papers). William Tabayoyong collaborates with scholars based in United States, Taiwan and Italy. William Tabayoyong's co-authors include Robert Abouassaly, Nicholas Zavazava, Ashish M. Kamat, Chung Lee, Luk Van Parijs, Ali Shah, Lee Ponsky, Debra McGivney, Chaitra Badve and Alice Yu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

William Tabayoyong

25 papers receiving 520 citations

Peers

Countries citing papers authored by William Tabayoyong

Since Specialization

Citations

This map shows the geographic impact of William Tabayoyong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Tabayoyong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Tabayoyong more than expected).

Fields of papers citing papers by William Tabayoyong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Tabayoyong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Tabayoyong. The network helps show where William Tabayoyong may publish in the future.

Co-authorship network of co-authors of William Tabayoyong

This figure shows the co-authorship network connecting the top 25 collaborators of William Tabayoyong. A scholar is included among the top collaborators of William Tabayoyong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Tabayoyong. William Tabayoyong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PHASE 1B/2 DOSE-EXPANSION, OPEN-LABEL STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER 2024 ·Urologic Oncology Seminars and Original Investigations ·Timothy D. Lyon, William Tabayoyong, Edward M. Messing, Jathin Bandari, Jacqueline Zummo, Wei Sun, (unknown), Eppie Brown, (unknown), (unknown), Nuwan D. Nanayakkara	1
2	ADVANCED-1: PHASE 1A DOSE-FINDING, OPEN-LABEL STUDY TO EVALUATE SAFETY AND TOXICITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER 2024 ·Urologic Oncology Seminars and Original Investigations ·Jathin Bandari, Gautam Jayram, William Tabayoyong, Edward M. Messing, (unknown), Neal D. Shore, Jacqueline Zummo, Wei Sun, (unknown), Eppie Brown, (unknown), Nuwan D. Nanayakkara	0
3	Effects of immune-enhancing nutrition on radical cystectomy outcomes: Primary results from the randomized phase III double-blind clinical trial (S1600). 2024 ·Journal of Clinical Oncology ·Jill Hamilton‐Reeves, Joseph M. Unger, Jeffrey M. Holzbeierlein, Danika L. Lew, James Ryan Mark, Siamak Daneshmand, Janet Baack Kukreja, Eugene K. Lee, William Tabayoyong, Dawn L. Hershman, Michael Fisch, N. Lynn Henry	3
4	Can preoperative planning using IRIS™ three-dimensional anatomical virtual models predict operative findings during robot-assisted partial nephrectomy? 2023 ·Asian journal of urology ·Ahmed Ghazi, Nitin Sharma, (unknown), Hani Rashid, (unknown), Thomas Frye, William Tabayoyong, Jonathan Bloom, Jean Joseph	3
5	Do Skills Naturally Transfer Between Multiport and Single-Port Robotic Platforms? A Comparative Study in a Simulated Environment 2022 ·Journal of Endourology ·Ahmed Ghazi, (unknown), (unknown), (unknown), (unknown), Richard K.K. Yuen, Karen Doersch, (unknown), William Tabayoyong, Jonathan Bloom, Hani Rashid, Nicholas Kavoussi, Jean Joseph	5
6	Utilizing head-mounted eye trackers to analyze patterns and decision-making strategies of 3D virtual modelling platform (IRIS™) during preoperative planning for renal cancer surgeries 2022 ·World Journal of Urology ·Rachel Melnyk, Yuxin Chen, (unknown), (unknown), (unknown), (unknown), Jonathan Bloom, William Tabayoyong, Thomas Frye, Hani Rashid, Jean Joseph, Ahmed Ghazi	6
7	Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study 2021 ·Urology ·(unknown), Rachel Melnyk, (unknown), Daniel C. Oppenheimer, (unknown), William Tabayoyong, Jonathan Bloom, Jathin Bandari, Thomas Frye, Jean Joseph, Eric Weinberg, Gary Hollenberg, Ahmed Ghazi	4
8	Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members 2020 ·Urologic Oncology Seminars and Original Investigations ·Justin T. Matulay, William Tabayoyong, (unknown), (unknown), Siamak Daneshmand, John L. Gore, Jeffrey M. Holzbeierlein, Lawrence I. Karsh, Simon P. Kim, Badrinath R. Konety, Roger Li, James M. McKiernan, Edward M. Messing, Gary D. Steinberg, Stephen B. Williams, Ashish M. Kamat	13
9	Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign 2018 ·European Urology Oncology ·Roger Li, Michael Metcalfe, William Tabayoyong, Charles C. Guo, Graciela M. Nogueras‐González, Neema Navai, H. Barton Grossman, Colin P. Dinney, Ashish M. Kamat	9
10	Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma 2018 ·Urologic Clinics of North America ·William Tabayoyong, Roger Li, Jianjun Gao, Ashish M. Kamat	14
11	Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non–muscle-invasive Bladder Cancer 2018 ·European Urology Focus ·William Tabayoyong, Ashish M. Kamat, Michael A. O’Donnell, James M. McKiernan, Mohamed D. Ray-Zack, Joan Palou, Maurizio Brausi, Peter C. Black, Stephen B. Williams	24
12	Current Use and Promise of Urinary Markers for Urothelial Cancer 2018 ·Current Urology Reports ·William Tabayoyong, Ashish M. Kamat	18
13	Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care? 2018 ·Canadian Urological Association Journal ·(unknown), Lee Ponsky, Edward E. Cherullo, William A. Larchian, Donald R. Bodner, Matthew M. Cooney, Rodney J. Ellis, Gregory T. MacLennan, Ben Johnson, William Tabayoyong, Robert Abouassaly	13
14	Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival 2017 ·Canadian Urological Association Journal ·Brian J. Minnillo, William Tabayoyong, (unknown), Matthew J. Maurice, Hui Zhu, Simon Kim, Robert Abouassaly	6
15	Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer—A Single-Institution Initial Analysis of Toxicity 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), William Tabayoyong, Lee Ponsky, Robert Abouassaly, Bryan Traughber, Pingfu Fu, (unknown), (unknown), Tarun K. Podder, (unknown), (unknown), Darpan I. Patel, Brian J. Minnillo, (unknown), Carlos A. González, Mitchell Machtay, Simon S. Lo, Rodney J. Ellis	1
16	Prostate Cancer Screening and the Associated Controversy 2015 ·Surgical Clinics of North America ·William Tabayoyong, Robert Abouassaly	62
17	HOXB4-Transduced Embryonic Stem Cell-Derived Lin−c- kit + and Lin−Sca-1+ Hematopoietic Progenitors Express H60 and Are Targeted by NK Cells 2009 ·The Journal of Immunology ·William Tabayoyong, (unknown), (unknown), Nicholas Zavazava	21
18	HOXB4 But Not BMP4 Confers Self-Renewal Properties to ES-Derived Hematopoietic Progenitor Cells 2008 ·Transplantation ·(unknown), (unknown), Kun‐Ming Chan, William Tabayoyong, Nicholas Zavazava	12
19	Reconstitution of Lethally Irradiated Adult Mice with Dominant Negative TGF-β Type II Receptor-Transduced Bone Marrow Leads to Myeloid Expansion and Inflammatory Disease 2002 ·The Journal of Immunology ·Ali Shah, William Tabayoyong, Simon Kimm, Seong‐Jin Kim, Luk Van Parijs, Chung Lee	34
20	Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice. 2002 ·PubMed ·Ali Shah, William Tabayoyong, Shilajit Kundu, Seong Jin Kim, Luk Van Parijs, (unknown), Eugene D. Kwon, Norman M. Greenberg, Chung Lee	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact